2. Academic Validation
  3. Chemogenetic attenuation of cortical seizures in nonhuman primates

Chemogenetic attenuation of cortical seizures in nonhuman primates

  • Nat Commun. 2023 Feb 28;14(1):971. doi: 10.1038/s41467-023-36642-6.
Naohisa Miyakawa 1,  Yuji Nagai 2,  Yukiko Hori 2,  Koki Mimura 2,  Asumi Orihara 2 3,  Kei Oyama 2,  Takeshi Matsuo 4,  Ken-Ichi Inoue 5,  Takafumi Suzuki 6,  Toshiyuki Hirabayashi 2,  Tetsuya Suhara 7,  Masahiko Takada 5,  Makoto Higuchi 2,  Keisuke Kawasaki 8,  Takafumi Minamimoto 9
Affiliations

Affiliations

  • 1 Department of Functional Brain Imaging, National Institutes for Quantum Science and Technology, Chiba, Japan. [email protected].
  • 2 Department of Functional Brain Imaging, National Institutes for Quantum Science and Technology, Chiba, Japan.
  • 3 Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • 4 Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
  • 5 Systems Neuroscience Section, Center for the Evolutionary Origins of Human Behavior, Kyoto University, Aichi, Japan.
  • 6 Center for Information and Neural Networks, National Institute of Information and Communications Technology, Suita, Japan.
  • 7 Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, Chiba, Japan.
  • 8 Department of Physiology, Niigata University School of Medicine, Niigata, Japan.
  • 9 Department of Functional Brain Imaging, National Institutes for Quantum Science and Technology, Chiba, Japan. [email protected].
PMID: 36854724 DOI: 10.1038/s41467-023-36642-6
Abstract

Epilepsy is a disorder in which abnormal neuronal hyperexcitation causes several types of seizures. Because pharmacological and surgical treatments occasionally interfere with normal brain function, a more focused and on-demand approach is desirable. Here we examined the efficacy of a chemogenetic tool-designer receptors exclusively activated by designer drugs (DREADDs)-for treating focal seizure in a nonhuman primate model. Acute infusion of the GABAA receptor antagonist bicuculline into the forelimb region of unilateral primary motor cortex caused paroxysmal discharges with twitching and stiffening of the contralateral arm, followed by recurrent cortical discharges with hemi- and whole-body clonic seizures in two male macaque monkeys. Expression of an inhibitory DREADD (hM4Di) throughout the seizure focus, and subsequent on-demand administration of a DREADD-selective agonist, rapidly suppressed the wide-spread seizures. These results demonstrate the efficacy of DREADDs for attenuating cortical seizure in a nonhuman primate model.

Figures
Products